Status:
UNKNOWN
Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18-75 years
Brief Summary
Aim of this study is to compare the efficacy of narrow band imaging (NBI) and autofluorescence imaging (AFI) to distinguish subtle mucosal change related to acid reflux that is not visible in standard...
Detailed Description
GERD is a common condition that develops when the reflux of gastric and/or duodenal contents causes troublesome symptoms with or without mucosal damage or complications. Despite the high prevalence of...
Eligibility Criteria
Inclusion
- Inclusion criteria
- GERD symptom: heartburn or regurgitation (either one) at least 2 days a week
- Presence of symptom for longer than 1 month before screening
- Provision of written informed consent
- Exclusion criteria:
- Any known esophageal disease or disorder, other than reflux esophagitis
- Active or healing gastroduodenal ulcer (except scars)
- History of esophageal or gastric surgery.
- Clinically significant heart, lung, liver or kidney disease
- Allergy to proton-pump inhibitor
- Pregnancy
Exclusion
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT01504971
Start Date
January 1 2011
End Date
December 1 2016
Last Update
September 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatient Department Building
Beijing, Beijing Municipality, China, 100853